The Digital Biomarker Summit USA will bring together industry leaders who will present the work that is currently underway with DHTs and digital biomarkers, aiming to drive the industry forward through education and collaboration.
This event will present examples across a variety of domains, including motor function/mobility, cognitive function, sensory function, and physiological measurement. Additionally, the Summit will demonstrate how design thinking methodologies are integral in developing digital biomarkers, as well as discuss regulatory guidance and frameworks to help the development and implementation of novel digital endpoints within clinical trials.
Stefan Avey is representing today IDEA-FAST at the US Digital Biomarkers Summit, with a presentation on developing cross-disease multicomponent digital biomarkers of fatigue! Read more on the summit here: digitalbiomarkersusa.panagorapharma.com/
